--- title: "China Resources Pharmaceutical: JZYY achieved a net profit of 307 million yuan in the first quarter, a year-on-year increase of 6.15%" type: "News" locale: "en" url: "https://longbridge.com/en/news/237733359.md" description: "According to the Zhitong Finance APP, China Resources Pharmaceutical announced the performance of JZYY for the three months ending March 31, 2025, with total operating revenue of 1.184 billion yuan, a year-on-year decrease of 7.03%; net profit of 307 million yuan, a year-on-year increase of 6.15%" datetime: "2025-04-28T00:08:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/237733359.md) - [en](https://longbridge.com/en/news/237733359.md) - [zh-HK](https://longbridge.com/zh-HK/news/237733359.md) generator: "portal-rs" --- # China Resources Pharmaceutical: JZYY achieved a net profit of 307 million yuan in the first quarter, a year-on-year increase of 6.15% According to the Zhitong Finance APP, China Resources Pharmaceutical (03320) released the performance report of JZYY for the three months ending March 31, 2025, with total operating revenue of 1.184 billion yuan, a year-on-year decrease of 7.03%; net profit of 307 million yuan, a year-on-year increase of 6.15% ### Related Stocks - [600750.CN](https://longbridge.com/en/quote/600750.CN.md) - [03320.HK](https://longbridge.com/en/quote/03320.HK.md) ## Related News & Research - [CATL Forges Strategic Co-op Deal with TAIJIN NEW ENERG and Others](https://longbridge.com/en/news/298254248.md) - [FOSUN PHARMA Opens 2.78% Higher After Proposing Up to HKD1B H Share Buyback](https://longbridge.com/en/news/298152618.md) - [Holcim commissions calcined clay line in Czechia to scale up ECOPlanet low-carbon cement](https://longbridge.com/en/news/298328251.md) - [04:17 ETEpicyt Pharma reports positive results in first-in-human study of BAFA in patients following gastric bypass surgery](https://longbridge.com/en/news/298283709.md) - [PXEN: Record revenues and operational milestones set the stage for accelerated 2027 development](https://longbridge.com/en/news/298172380.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**